Medical Foods Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2020-2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Medical Foods Market, By Route of Administration

7.1.  Medical Foods Market, By Route of Administration Type, 2020-2030

7.1.1.    Oral

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Enteral

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Medical Foods Market, By Product

8.1.  Medical Foods Market, By Product, 2020-2030

8.1.1.    Pills

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Powder

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Others

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Medical Foods Market, By Application

9.1.  Medical Foods Market, By Application, 2020-2030

9.1.1.    Chronic Kidney Disease

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Minimal Hepatic Encephalopathy

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Chemotherapy-induced Diarrhea

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Pathogen Related Infections

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Diabetic Neuropathy

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    ADHD

9.1.6.1.        Market Revenue and Forecast (2016-2030)

9.1.7.    Depression

9.1.7.1.        Market Revenue and Forecast (2016-2030)

9.1.8.    Alzheimer's Disease

9.1.8.1.        Market Revenue and Forecast (2016-2030)

9.1.9.    Nutritional Deficiency

9.1.9.1.        Market Revenue and Forecast (2016-2030)

9.1.10.  Orphan Diseases

9.1.10.1.      Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Medical Foods Market, By Sales Channel

10.1.        Medical Foods Market, By Sales Channel, 2020-2030

10.1.1.  Online Sales

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Retail Sales

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Institutional Sales

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Medical Foods Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Route of Administration (2016-2030)

11.1.2.  Market Revenue and Forecast, By Product (2016-2030)

11.1.3.  Market Revenue and Forecast, By Application (2016-2030)

11.1.4.  Market Revenue and Forecast, By Sales Channel (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.1.5.2.      Market Revenue and Forecast, By Product (2016-2030)

11.1.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.1.5.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.1.6.2.      Market Revenue and Forecast, By Product (2016-2030)

11.1.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.1.6.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Route of Administration (2016-2030)

11.2.2.  Market Revenue and Forecast, By Product (2016-2030)

11.2.3.  Market Revenue and Forecast, By Application (2016-2030)

11.2.4.  Market Revenue and Forecast, By Sales Channel (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.2.5.2.      Market Revenue and Forecast, By Product (2016-2030)

11.2.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.2.5.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.2.6.2.      Market Revenue and Forecast, By Product (2016-2030)

11.2.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.2.6.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.2.7.2.      Market Revenue and Forecast, By Product (2016-2030)

11.2.7.3.      Market Revenue and Forecast, By Application (2016-2030)

11.2.7.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.2.8.2.      Market Revenue and Forecast, By Product (2016-2030)

11.2.8.3.      Market Revenue and Forecast, By Application (2016-2030)

11.2.8.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Route of Administration (2016-2030)

11.3.2.  Market Revenue and Forecast, By Product (2016-2030)

11.3.3.  Market Revenue and Forecast, By Application (2016-2030)

11.3.4.  Market Revenue and Forecast, By Sales Channel (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.3.5.2.      Market Revenue and Forecast, By Product (2016-2030)

11.3.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.3.5.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.3.6.2.      Market Revenue and Forecast, By Product (2016-2030)

11.3.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.3.6.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.3.7.2.      Market Revenue and Forecast, By Product (2016-2030)

11.3.7.3.      Market Revenue and Forecast, By Application (2016-2030)

11.3.7.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.3.8.2.      Market Revenue and Forecast, By Product (2016-2030)

11.3.8.3.      Market Revenue and Forecast, By Application (2016-2030)

11.3.8.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Route of Administration (2016-2030)

11.4.2.  Market Revenue and Forecast, By Product (2016-2030)

11.4.3.  Market Revenue and Forecast, By Application (2016-2030)

11.4.4.  Market Revenue and Forecast, By Sales Channel (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.4.5.2.      Market Revenue and Forecast, By Product (2016-2030)

11.4.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.4.5.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.4.6.2.      Market Revenue and Forecast, By Product (2016-2030)

11.4.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.4.6.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.4.7.2.      Market Revenue and Forecast, By Product (2016-2030)

11.4.7.3.      Market Revenue and Forecast, By Application (2016-2030)

11.4.7.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.4.8.2.      Market Revenue and Forecast, By Product (2016-2030)

11.4.8.3.      Market Revenue and Forecast, By Application (2016-2030)

11.4.8.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Route of Administration (2016-2030)

11.5.2.  Market Revenue and Forecast, By Product (2016-2030)

11.5.3.  Market Revenue and Forecast, By Application (2016-2030)

11.5.4.  Market Revenue and Forecast, By Sales Channel (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.5.5.2.      Market Revenue and Forecast, By Product (2016-2030)

11.5.5.3.      Market Revenue and Forecast, By Application (2016-2030)

11.5.5.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Route of Administration (2016-2030)

11.5.6.2.      Market Revenue and Forecast, By Product (2016-2030)

11.5.6.3.      Market Revenue and Forecast, By Application (2016-2030)

11.5.6.4.      Market Revenue and Forecast, By Sales Channel (2016-2030)

Chapter 12.  Company Profiles

12.1.              Danone

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Nestle Nutrition

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Abbott Nutrition

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Targeted Medical Pharma, Inc.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Primus Pharmaceuticals, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Mead Johnson & Company, LLC.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Medtrition, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Fresenius Kabi AG

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Report Details

  • Report Code:35989
  • Category:Healthcare
  • No. of Pages:200
  • Format:PDF/PPT/Excel
  • Published:November 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers